Can response duration after the first rituximab treatment be used in timing of rituximab retreatment?

Scandinavian journal of rheumatology

Volumn 42, Issue 3, 2013, Pages 251-252

  van Herwaarden, N ^a   van der Maas, A ^a   Jansen, T L ^a   Dutmer, E A ^a   Hartkamp, A ^a   van Riel, P L ^a   Kievit, W ^a   van den Bemt, B J ^a   den Broeder, A A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; MONOCLONAL ANTIBODY; RITUXIMAB;

AGED; FEMALE; HUMAN; LETTER; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS;

AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84880181186     PISSN: None     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2013.765030     Document Type: Letter

References (0)